Maximino J. Abraldes

Santiago De Compostela, GA 15706, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration.

Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 07, 2026

Beyond monotherapy in diabetic macular edema: sequential and combination therapy-when and why?

Beyond monotherapy in diabetic macular edema: sequential and combination therapy-when and why?

Journal: Archivos de la Sociedad Espanola de Oftalmologia

Published: March 06, 2026

Survey of the current state of intravitreal therapy in Spain.

Survey of the current state of intravitreal therapy in Spain.

Journal: Archivos de la Sociedad Espanola de Oftalmologia

Published: August 18, 2025

Vascular endothelial growth factor inhibitors outcomes in good vision eyes with neovascular age-related macular degeneration: Fight Retinal Blindness! SPAIN Report 4.

Vascular endothelial growth factor inhibitors outcomes in good vision eyes with neovascular age-related macular degeneration: Fight Retinal Blindness! SPAIN Report 4.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: August 02, 2025

Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database.

Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database.

Journal: The British journal of ophthalmology

Published: April 04, 2024

Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain.

Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain.

Journal: Ophthalmology and therapy

Published: March 22, 2024

Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain.

Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain.

Journal: Ophthalmology and therapy

Published: March 22, 2024

Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study.

Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study.

Journal: Eye (London, England)

Published: January 22, 2024

Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab.

Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 10, 2023

The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration.

The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration.

Journal: Pharmaceutics

Published: November 28, 2023

Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration.

Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration.

Journal: Ophthalmology. Retina

Published: October 25, 2023

Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration.

Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration.

Journal: Investigative ophthalmology & visual science

Published: October 20, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026